Farmaceutisk aktive forbindelser som AXL-inhibitorer

摘要

The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I):
and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.